CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
Neofect RAPAEL Smart Glovedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03741400
NCT03741400N/ACompleted

Virtual Reality Glove for Hand and Arm Rehabilitation After Stroke

Stanford University·interventional·Posted Nov 14, 2018·Updated Oct 9, 2024

In Brief

A clinical study evaluating Neofect RAPAEL Smart Glove for Stroke, Acute and Cerebral Infarction. Completed, enrolled 60 participants across 4 sites in 2 countries.

Detailed Summary

The Virtual Reality Glove for Hand and Arm Rehabilitation (vREHAB) trial is a randomized, controlled, phase 3 trial aiming to evaluate the safety, usability, and efficacy of a virtual reality biofeedback system (Neofect RAPAEL Smart Glove) to promote recovery of distal arm and hand function in the acute and subacute period after stroke, as compared to standard of care therapy. The aims of the study is to demonstrate: 1. the effect of Smart Glove use on functional recovery, in addition to standard of care rehabilitation therapy. 2. the feasibility of increasing the dose of rehabilitation in acute stroke patients with the Smart Glove. 3. the effect of Smart Glove use on quality of life.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesBelgium, United States

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedNov 14, 2018
Enrollment StartOct 1, 2018
Primary CompletionSep 15, 2023
TodayJul 2, 2026
Enrollment to primary: 5.0 yearsPosted 7.6 years ago

Interventions

Neofect RAPAEL Smart Glovedevice

The Neofect Rapael Smart Glove is a biofeedback system designed for upper extremity rehabilitation in stroke survivors. It includes a glove-shaped sensor device and a software application.